Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.
Haemel
Anna K
AK
Departments of Dermatology and Pediatrics, University of Wisconsin School of Medicine and Public Health, 1 S Park St, Seventh Floor, Madison, WI 53715. jteng@dermatology.wisc.edu.
O'Brian
Amy L
AL
Teng
Joyce M
JM
D000287:Administration, Topical; D000293:Adolescent; D018322:Angiofibroma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002610:Cheek; D003937:Diagnosis, Differential; D005153:Facial Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D020123:Sirolimus / Q000008:administration & dosage*; D014402:Tuberous Sclerosis / Q000150:complications* / Q000188:drug therapy
D007166:Immunosuppressive Agents; D020123:Sirolimus